Recap: Amryt Pharma Q4 Earnings

 

Amryt Pharma AMYT reported its Q4 earnings results on Wednesday, March 9, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Amryt Pharma beat estimated earnings by 53.33%, reporting an EPS of $-0.07 versus an estimate of $-0.15.

Revenue was up $12.31 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.1 which was followed by a 6.67% increase in the share price the next day.

Here's a look at Amryt Pharma's past performance:

 

Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate -0.17 0.19 0.13 -0.34
EPS Actual -0.07 -0.04 -0.09 -0.28
Revenue Estimate 52.78M 50.49M 46.15M 41.97M
Revenue Actual 56.52M 62.76M 48.43M 42.52M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EarningsNewsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!